A glycoengineered therapeutic anti-HBV antibody that allows increased HBsAg immunoclearance improves HBV suppression in vivo
一种经糖基化改造的治疗性抗HBV抗体,可增强HBsAg的免疫清除,从而改善体内HBV抑制效果。
期刊:Frontiers in Pharmacology
影响因子:4.4
doi:10.3389/fphar.2023.1213726
Min You # ,Fentian Chen # ,Chao Yu # ,Yuanzhi Chen ,Yue Wang ,Xue Liu ,Xueran Guo ,Bing Zhou ,Xin Wang ,Boya Zhang ,Mujin Fang ,Tianying Zhang ,Ping Yue ,Yingbin Wang ,Quan Yuan ,Wenxin Luo